Two-factor authentication required for electronic prescription of controlled substances
The U.S. Drug Enforcement Administration (DEA) issued a new rule requiring doctors and pharmacists to use two-factor authentication when electronically prescribing controlled substances.
The rule could mean big business for the biometrics industry, says Bill Spence, vice president of transaction systems for fingerprint biometric manufacturer Lumidigm.
Titled, “Electronic Prescriptions for Controlled Substances,” the rule became effective June 1. It does not require doctors to submit these prescriptions electronically nor does it require pharmacies to accept electronic submissions, but it does govern the process when utilized.
There are 635 words in the rest of this article …
Library Access Required
Library subscribers have access to the full archives of more than 10,000 original news items and feature articles published by AVISIAN’s suite of ID technology publications (ContactlessNews.com, CR80News.com, DigitalIDNews.com, FIPS201.com, NFCNews.com, RFIDNews.org, SecureIDNews.com, and ThirdFactor.com).
For just $49, you receive unlimited password-protected access to content on all of AVISIAN’s sites for an entire year. Your subscription helps fund the continued creation of independent, insightful content. Find out more.
Sign in as a Subscriber
If you are already a subscriber, you may sign in now. Enter your Email Address and Password and click Sign In.
If you have forgotten your password, enter just your Email Address, and click Send Password.
